GA

Giuseppe Alvaro

AL Autifony Therapeutics Limited: 25 patents #1 of 9Top 15%
GL Glaxo Group Limited: 13 patents #60 of 1,368Top 5%
SL Smithkline Beecham Limited: 8 patents #141 of 1,624Top 9%
GL Glaxosmithkline: 4 patents #75 of 646Top 15%
CL Convergence Pharmaceuticals Limited: 4 patents #9 of 38Top 25%
NL Nerre Therapeutics Limited: 3 patents #2 of 11Top 20%
SB Smithkline Beechan: 1 patents #1 of 38Top 3%
📍 Stevenage, GB: #1 of 520 inventorsTop 1%
Overall (All Time): #38,906 of 4,157,543Top 1%
60
Patents All Time

Issued Patents All Time

Showing 26–50 of 60 patents

Patent #TitleCo-InventorsDate
8822504 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanomethylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as NK1 receptor antagonists Agostino Marasco 2014-09-02
8722695 Imidazolidinedione derivatives Anne DECOR, Stefano Fontana, Dieter Hamprecht, Charles Large, Agostino Marasco 2014-05-13
8633214 Spiro (piperidine-4,2′-pyrrolidine)-1-(3,5-trifluoromethylphenyl) methylcarboxamides as NK1 tachikynin receptor antagonists Emiliano Castiglioni, Agostino Marasco 2014-01-21
8367692 Spiro (piperidine-4,2′-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 tachikynin receptor antagonists Emiliano Castiglioni, Agostino Marasco 2013-02-05
8344005 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoMethylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2 as NK1 receptor antagonists Agostino Marasco 2013-01-01
8153681 Method of treating epilepsy by administering 5-(4{[(2-fluorophenyl)methyl]oxy}phenyl)prolinamide Markus Bergauer, Roberto Profeta, Riccardo Giovannini 2012-04-10
8153623 Compounds David Amantini, Markus Bergauer, Francesca Bonetti, Roberto Profeta 2012-04-10
8143306 Methods of treating bipolar disorders Markus Bergauer, Roberto Profeta, Riccardo Giovannini 2012-03-27
8133908 Heteroaryl derivatives of N-{[(1S,4S,6S)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-amine David Amantini, Emiliano Castiglioni, Romano Di Fabio, Francesca Pavone 2012-03-13
8129384 Imidazo[1,2-a]pyrazines as orexin receptor antagonists David Amantini, Sandro Belvedere 2012-03-06
8097618 Pyridine derivatives and their use in the treatment of psychotic disorders Sandro Belvedere 2012-01-17
8093268 Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-) Charles Large 2012-01-10
8093255 Imidazo[1,2-A]pyrimidines as orexin receptor antagonists David Amantini, Sandro Belvedere 2012-01-10
7919491 Pyridine derivatives and their use in the treatment of psychotic disorders Sandro Belvedere 2011-04-05
7855218 Compounds Daniele Andreotti, Markus Bergauer, Riccardo Giovannini, Agostino Marasco 2010-12-21
7803833 Compounds David Amantini, Markus Bergauer, Francesca Bonetti, Roberto Profeta 2010-09-28
7683056 Pyridine derivatives and their use in the treatment of psychotic disorders Sandro Belvedere 2010-03-23
7655693 Compounds Markus Bergauer, Roberto Profeta, Riccardo Giovannini 2010-02-02
7652012 2-(R)-(4-fluoro-2-methyl-phenyl)-4-(S)-((8aS)-6-oxo-hexahydro-pyrrolo[1,2-a]-pyrazin-2-yl)-piperidine-1-carboxylic acid [1-(R)-3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide maleate and pharmaceutical compositions thereof Romano Di Fabio, Maria Tranquillini, Simone Spada 2010-01-26
7648990 Chemical compounds Paola Maragni, Marsia Tampieri 2010-01-19
7625904 Methods for the treatment of sleep disorders Romano Di Fabio, Riccardo Giovannini, Giuseppe Guercio, Yves St-Denis, Antonella Ursini 2009-12-01
7534893 Imidazol-2-one compounds useful in the treatment of various disorders Damiano Ghirlanda 2009-05-19
7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases Alfredo Paio, Alessandro Pontiroli, Simone Spada, Maria Tranquillini 2009-01-27
7345041 Chemical compounds Romano Di Fabio, Riccardo Giovannini, Giuseppe Guercio, Yves St-Denis, Antonella Ursini 2008-03-18
7294630 Piperazinyl piperidine tachykinin antagonists 2007-11-13